DRUG Operating Cash Flow Growth
Bright Minds Biosciences Inc · Operating Cash Flow Growth
DRUG Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-140.26%period ending
DRUG Quarterly Cash from Operations YoY % (-819.96% → -140.26%)
Year-over-year change
High-resolution chart · PNG
DRUG operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -140.2622% | |
| -291.5524% | |
| -289.1812% | |
| -173.7673% | |
| -1,559.0002% | |
| -201.244% | |
| -81.7805% | |
| 61.3227% | |
| 114.5503% | |
| 46.7717% | |
| 69.1371% | |
| 43.7411% | |
| 42.3304% | |
| 58.5096% | |
| 46.199% | |
| 10.9214% | |
| 3.7229% | |
| -159.01% | |
| -800.9661% | |
| -1,034.4812% | |
| -15,117.6762% | |
| -3,621.1882% | |
| -819.9571% |